Clik here to view.
COO Alexander Karle appointed CEO of Evaluate Ltd
LONDON & BOSTON & TOKYO Life science market intelligence company, Evaluate Ltd, today announced the appointment of Alex Karle to the role of Chief Executive Officer. Dr Jonathan de Pass,...
View ArticleClik here to view.
Solution Designed Specifically for Med/Surg Floors Addresses Unmet Patient...
RYDALMERE, Australia Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, today introduced the industry’s most comprehensive clinical...
View ArticleClik here to view.
国际生物界人士齐聚日本！综合性生物技术商业盛会——BioJapan 2014即将举办
东京 (美国商业资讯)–BioJapan 2014 – 世界商业论坛 –将于2014年10月15（周三）-17日（周五）在横滨太平洋会展中心(Pacifico Yokohama)的C馆、D馆及分馆举行，为期三天。 BioJapan 2013 – Partnering Area – (Photo: Business Wire)...
View ArticleClik here to view.
Hatchtech Announces Successful Phase 3 Study Results for Xeglyze™ Lotion
MELBOURNE, Australia Specialty pharmaceutical company Hatchtech Pty Ltd today announced positive results from its two pivotal Phase 3 clinical studies evaluating Xeglyze™ Lotion (formerly DeOvo...
View ArticleClik here to view.
Teleflex to Present for the First Time at the 32nd Annual World Congress of...
WAYNE, Pa. Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, will present for the first time at the 32nd Annual World Congress...
View ArticleClik here to view.
Imperial College London to Present First Public HBV Data from CN Bio in Vitro...
OXFORD, England CN Bio Innovations Ltd (CN Bio), an expert in developing human biomimetic platforms to test and develop therapeutics for serious diseases, has announced that data from its research...
View ArticleClik here to view.
CartiHeal Granted Four Patents Covering Agili-C™ Cartilage Regeneration...
KFAR SABA, Israel CartiHeal (2009) Ltd., a privately held medical device company headquartered in Kfar Saba, Israel, announces the issuance of four patents — three in the U.S. and one in Japan — for...
View ArticleClik here to view.
China’s Food and Drug Administration has Cleared NovaBay’s NeutroPhase Skin...
EMERYVILLE, Calif. & SHANGHAI NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective...
View ArticleClik here to view.
Navidea Enters Lymphoseek® Development and Commercialization Agreement for China
DUBLIN, Ohio Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) has entered an exclusive agreement with a wholly-owned subsidiary of Hainan Sinotau Pharmaceutical Co., Ltd., a pharmaceutical...
View ArticleClik here to view.
GenoLogics Enters Agreement with Illumina to Provide Laboratory Information...
VICTORIA, British Columbia GenoLogics today announced it has been selected by Illumina as the preferred laboratory information management system (LIMS) provider to support HiSeq X Ten sequencing...
View ArticleClik here to view.
Discover the Latest in Forensics at the 25th Annual International Symposium...
MADISON, Wis. When the International Symposium on Human Identification (ISHI) began in 1989, forensics was an emerging science, rife with possibilities. Few could have predicted that 25 short years...
View ArticleClik here to view.
Rheonix Lectures in China on Its Innovative Molecular Platform
ITHACA, N.Y. Rheonix, Inc., a developer of fully automated molecular testing solutions, recently spoke at Beijing University of Chemical Technology, School of Information and Technology. Dr....
View ArticleClik here to view.
KCI、LifeCell和Systagenix合并为一家公司，品牌重塑为Acelity
圣安东尼奥 (美国商业资讯) — Centaur Guernsey L.P. Inc. (Centaur)今天宣布成立Acelity，对自身及其子公司Kinetic Concepts, Inc. (KCI)、LifeCell Corporation (LifeCell)和Systagenix Wound Management, Limited (Systagenix)成功进行了品牌重塑。...
View ArticleClik here to view.
KCI、ライフセル、シスタジェニックスが統合し、新ブランドAcelityとして一社に
サンアントニオ （ビジネスワイヤ） — セントーア・ガーンジー（セントーア）は本日、Acelityの始動を発表しました。Acelityは、当社および当社子会社のキネティック・コンセプツ（KCI)、ライフセル・コーポレーション(ライフセル)、シスタジェニックス・ウンド・マネジメント(シスタジェニックス)を効果的にリブランディングするものです。 Acelity...
View ArticleClik here to view.
米国ボストン・ストラテジクス社: 次世代型医薬品R&Dプラットフォーム（“True” Open Innovation™）を駆使してグローバル医薬品開発
ボストン （ビジネスワイヤ） — Boston Strategics Corporation（BSC）は、米国マサチューセッツ州ボストンに本社を置く臨床ステージの総合医薬品研究開発（R&D）会社です。既成インフラに依らず、独自のグローバル・ネットワークを駆使する“True” Open Innovation™...
View ArticleClik here to view.
Sosei Group Announces Positive Results for Ultibro® and Seebri® Presented at...
TOKYO Sosei Group Corporation (“Sosei”)(TOKYO:4565) confirms the new data from three clinical trials presented by Novartis at the European Respiratory Society (ERS) International Congress, September...
View ArticleClik here to view.
Asfotase Alfa Granted Orphan Drug Designation in Japan
CHESHIRE, Conn. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation (ODD) to asfotase alfa for...
View ArticleClik here to view.
ReproCELL Acquires the iPS Cell Business Unit of Stemgent, Inc.
YOKOHAMA, Japan ReproCELL (JASDAQ:4978) announced that it will acquire the iPS Cell Business Unit of Stemgent, Inc. This acquisition allows the ReproCELL Group to expand the product lineups of its...
View ArticleClik here to view.
GenoLogics与Illumina签署协议，提供面向HiSeq X Ten系统的实验室信息系统
不列颠哥伦比亚省维多利亚 (美国商业资讯) — GenoLogics今天宣布，Illumina已选择该公司作为首选的实验室信息管理系统(LIMS)提供商，来支持HiSeq X Ten测序系统客户。根据协议，两家公司正密切合作，来提供面向HiSeq X...
View ArticleClik here to view.
ACM Global Central Laboratory Officially Opens New Shanghai Lab Facility
ROCHESTER, N.Y. ACM Global Central Laboratory, a diagnostic central laboratory delivering high-quality testing services that optimize clinical trial outcomes, today announced the official opening of...
View Article